02 September 2022 | News
University of Sydney announces largest ever capital investment
Image credit: sydney.edu.au
The Sydney Biomedical Accelerator (SBA) will create a first-in-Australia, 36,000 sq mt health, education, and research precinct co-located at Royal Prince Alfred Hospital and the University’s Camperdown campuses, within the Tech Central precinct.
The Accelerator will tackle some of the most complex health challenges, including cancer and neurodegenerative diseases and position Sydney as a global leader in biomedical research.
Scientists at the Accelerator will conduct cutting edge research into the building blocks of life, regenerative medicine, drug discovery and medical device development and harness the latest in nanotechnology and gene and stem cell therapy to transform health outcomes in the state.
Over 1200 world class biomedical researchers and clinician scientists will be located onsite at the SBA, including over 800 university laboratory researchers and PhD students and 100 industry researchers.
The Vice-Chancellor and President, Professor Mark Scott AO said the SBA is a partnership between the University, the Sydney Local Health District and the NSW Government, in collaboration with the Centenary Institute.
Image caption- Richard Alcock (Western Sydney Local Health District), Elizabeth Koff (Telstra Health), Susan Pearce (NSW Health), Prof Mark Scott (University of Sydney), Dr Teresa Anderson (Sydney Local Health District) and Prof Robyn Ward (University of Sydney) at the announcement event.